Search results
Results from the WOW.Com Content Network
The COVID-19 pandemic in Iran has resulted in 7,627,863 [2] confirmed cases of COVID-19 and 146,837 [2] deaths. On 19 February 2020, Iran reported its first confirmed cases of infections in Qom. [5] The virus may have been brought to the country by a merchant from Qom who had travelled to China. [6]
COVIran Barekat [3] (Persian: کووایران برکت) is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical Group. [4] [5] [6] It is an inactivated virus-based vaccine. [3] Iranian authorities have authorized its emergency use.
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 – March 2020; Families First Coronavirus Response Act – March 2020; Coronavirus Aid, Relief, and Economic Security Act (CARES Act) – Includes $1200 stimulus checks, March 2020; Paycheck Protection Program and Health Care Enhancement Act – April 2020
From Caracas to Tehran, officials are calling on the Trump administration to ease crippling economic sanctions they contend are contributing to the growing death toll caused by the coronavirus ...
In 2020-2021, amid the COVID-19 pandemic in Iran, Iran developed multiple COVID-19 vaccines [42] with five that have received emergency use authorization (COVIran Barekat, [43] Pasteurcovac, [44] FAKHRAVAC, [45] COVAX-19 [46] and Razi Cov Pars [47]). The new drugs launched in Iran for the treatment of MS include an interferon beta-1b by ...
Iran fully vaccinated almost 50 percent of the population by November 5th 2021, and permanently halted vaccine shot import. General population were to take the Sinopharm BIBP vaccine. [ 1 ] From December 2021 electronic vaccine certificate were mandatory for work, [ 2 ] [ 3 ] [ 4 ] mandatory service in Iranian Armed Forces , universities, and ...
The destination of the aid ranges from hospitals, COVID-19 healthcare workers, research on the vaccine, to societies vulnerable. People donating includes the government of said country, notable people, organizations and institutions, charities, as well as regular people.
A number of COVID-19 vaccines have been developed in China, which have been used in its vaccination programme and international vaccine diplomacy. Through November 2021, China was the world's largest exporter of COVID-19 vaccines, with a cumulative share of around 40% of worldwide exports (totalling around 1.5 billion doses), according to the ...